Skip to main content
Clinical Trials/NCT02363140
NCT02363140
Unknown
Not Applicable

Magnetic Resonance Imaging to Assess Changes in Meniscus Vascularity

The Leeds Teaching Hospitals NHS Trust0 sites48 target enrollmentJune 2012
ConditionsMeniscus Tears

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Meniscus Tears
Sponsor
The Leeds Teaching Hospitals NHS Trust
Enrollment
48
Primary Endpoint
Primary outcome is to assess meniscus vascularity in-vivo by use of MR imaging technique.
Last Updated
10 years ago

Overview

Brief Summary

The menisci in the knee joint are important for normal functioning of the knee. Meniscus tears are amongst the commonest of injuries to the knee. The pattern and blood supply of the meniscus tears determines the treatment plan and outcome. The surgeon identifies the blood supply to the meniscus tear area during the arthroscopy(key hole operation) and decides the treatment option ie repair versus partial meniscectomy.

This study aims to identify any changes that occur in the meniscus blood supply. The following are the main aims of the 'MOVE'study-

  1. Use of non-invasive methods ie MRImaging to assess meniscus vascularity to preoperatively plan treatment and advice patient on recovery.
  2. The study would assess changes in meniscus blood supply depending on age of the patient.
  3. The study aims to assess the alteration in meniscus blood supply following an arthroscopic(key hole) meniscal repair operation.
Registry
clinicaltrials.gov
Start Date
June 2012
End Date
June 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
The Leeds Teaching Hospitals NHS Trust
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for Group I,II
  • Patients should be aged 18-20 years or 35-45years
  • Asymptomatic knee for past 6 months.
  • Painless flexion-extension movements at knee joint.
  • Inclusion criteria for Group III
  • Patients should be aged 75 or older
  • Knee X-ray showing no more than Kellgren-Lawrence grade II osteoarthrtis
  • No clinical suspicion of meniscus tear
  • Painless flexion-extension movements at knee joint.
  • Inclusion criteria for Group IV

Exclusion Criteria

  • Proven Polyarthritis / Polyarthralgia secondary to Rheumatoid arthritis, Gout, Lupus, Ankylosing Spondylosis, Psoriatic arthritis
  • Any previous surgical procedure(open or arthroscopic) involving the knee joint.(baring the current meniscus repair in Group IV participants)
  • Patients unable to give informed consent.
  • Patients with contraindication for MR Imaging - Metal implants, prosthetic heart valves, pacemakers, metal foreign bodies, VP shunts, pregnancy, cochlear implant, metal clips in the brain, Patients with static tremor i.e. Parkinson's disease.
  • Patients with contraindications for contrast agent - Renal impairment, Previous allergic reaction.

Outcomes

Primary Outcomes

Primary outcome is to assess meniscus vascularity in-vivo by use of MR imaging technique.

Time Frame: 6 months

Similar Trials